448P Efficacy of combinations of BRAF inhibitors and anti-EGFR antibodies in metastatic colorectal carcinoma (mCRC) patients with mBRAF in the real clinical practice

Autor: Fedyanin, M., Elsnukaeva, H., Demidova, I., Stroyakovskiy, D., Shelygin, Y., Tsukanov, A., Panina, M., Moiseenko, F., Karpenko, E., Bolotina, L., Kudryavtseva, A., Filipenko, M., Oskorbin, I., Vladimirova, L.Y., Timoshkina, N.N., Kit, O.I., Stroganova, A., Dranko, S., Tryakin, A., Tjulandin, S.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S557-S558
Databáze: ScienceDirect